Ischemic Stroke Epidemiology Forecast 2025-2034

Ischemic Stroke Epidemiology Forecast Report Coverage

Expert Market Research's “Ischemic Stroke Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of ischemic stroke. It projects the future incidence and prevalence rates of ischemic stroke across various populations. The study covers age and type as major determinants of the ischemic stroke-affected population. The report highlights patterns in the prevalence of ischemic stroke over time and projects future trends based on multiple variables.

Ischemic Stroke: Disease Overview

Ischemic stroke is the most common stroke type, which occurs when the blood vessels in the brain are narrowed or blocked. The accumulation of fatty deposits in the blood vessels leads to reduced blood flow, known as ischemia. An ischemic stroke can also occur if blood clots or other debris gets lodged in the blood vessels in the brain. Weakness or paralysis on one side of the face or body, aphasia, and slurred or garbled speech are some of the most common symptoms of ischemic stroke.

Ischemic Stroke: Treatment Overview

Thrombolytic therapy and thrombectomy are the two most common treatments for ischemic stroke. Thrombolytic therapy includes medications that help dissolve clots, whereas thrombectomy is a surgery that is performed to remove a blood clot. Anticoagulant medications or blood thinners are prescribed to some patients after thrombolytic therapy. Oxygen therapy helps in restoring oxygen to the brain.

Epidemiology

The ischemic stroke epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for ischemic stroke by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for ischemic stroke and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Ischemic strokes, in which blood flow to the brain is blocked, account for approximately 87% of all strokes.
• In 2020, the global prevalence of acute ischemic stroke (AIS) was reported to be 68.16 million people.
• High blood pressure, obesity, diabetes, high cholesterol, and smoking are the leading causes of ischemic stroke. It is estimated that 1 in 3 adults in the United States has at least one of these risk factors.
• Studies show that disparities exist in stroke incidence and outcomes across racial and ethnic groups. It is reported that non-Hispanic Black and Pacific Islander adults have the highest stroke-related mortality rates.

Country-wise Ischemic Stroke Epidemiology

The ischemic stroke epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of ischemic stroke varies significantly between countries due to differences in the prevalence of risk factors (hypertension, diabetes, smoking, obesity, and high cholesterol), healthcare systems, lifestyle factors, and socioeconomic conditions. In the United Kingdom, 100,000 individuals are affected by a stroke every year. It is estimated that about 85% of strokes in the country are ischemic strokes.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of ischemic stroke based on several factors.
• The Ischemic Stroke Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of ischemic stroke are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of ischemic stroke epidemiology in the 8 major markets?
• What will be the total number of patients with ischemic stroke across the 8 major markets during the forecast period?
• What was the country-wise prevalence of ischemic stroke in the 8 major markets in the historical period?
• Which country will have the highest number of ischemic stroke patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of ischemic stroke during the forecast period of 2025-2034?
• What are the currently available treatments for Ischemic Stroke?
• What are the disease risks, signs, symptoms, and unmet needs of ischemic stroke?

Related Reports

Ischemic Stroke Market

Haemorrhagic Stroke Treatment Market